A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 45,800 shares of SANA stock, worth $75,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,800
Previous 100,800 54.56%
Holding current value
$75,570
Previous $550,000 65.45%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.76 - $6.86 $450,895 - $822,644
119,919 Added 201.97%
179,294 $745,000
Q2 2024

Aug 14, 2024

SELL
$5.23 - $10.44 $9.56 Million - $19.1 Million
-1,827,781 Reduced 96.85%
59,375 $324,000
Q1 2024

May 15, 2024

BUY
$4.2 - $11.27 $7.76 Million - $20.8 Million
1,847,280 Added 4632.56%
1,887,156 $18.9 Million
Q4 2023

Feb 14, 2024

SELL
$2.8 - $4.55 $687,668 - $1.12 Million
-245,596 Reduced 86.03%
39,876 $162,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $625,970 - $1.03 Million
166,040 Added 139.02%
285,472 $1.1 Million
Q2 2023

Aug 14, 2023

SELL
$3.22 - $7.53 $4.73 Million - $11.1 Million
-1,469,949 Reduced 92.49%
119,432 $711,000
Q1 2023

May 15, 2023

BUY
$3.11 - $4.92 $2.29 Million - $3.63 Million
737,578 Added 86.59%
1,589,381 $5.2 Million
Q4 2022

Feb 14, 2023

SELL
$3.19 - $6.46 $1.07 Million - $2.17 Million
-335,609 Reduced 28.26%
851,803 $3.36 Million
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $6.25 Million - $10.1 Million
1,119,195 Added 1640.64%
1,187,412 $7.13 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $314M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.